Buprenorphine Sublingual C Iii + Lopinavir Interaction
Unknowninteraction on record
Description
Examples: efavirenz, nevirapine, etravirine, delavirdine Antiretrovirals: Protease inhibitors (PIs) Clinical Impact: Studies have shown some antiretroviral protease inhibitors (PIs) with CYP3A4 inhibitory activity (nelfinavir, lopinavir/ritonavir, ritonavir) have little effect on buprenorphine pharmacokinetic and no significant pharmacodynamic effects.
Source: FDA drug label - buprenorphine sublingual c-iii